Literature DB >> 17028487

Prehypertension: an important preventive medicine concept--or marketing ploy?

Barry J Materson1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17028487      PMCID： PMC8109361          DOI： 10.1111/j.1524-6175.2006.05820.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  Unease on industry's role in hypertension debate.

Authors:  Stephanie Saul
Journal:  N Y Times Web       Date:  2006-05-20

2.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

3.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

4.  The Trial of Preventing Hypertension (TROPHY) as seen through the eyes of the Hypertension Writing Group's expanded definition of hypertension.

Authors:  Thomas D Giles
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

5.  Expanding the definition and classification of hypertension.

Authors:  Barry J Materson
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738
  5 in total
  1 in total

1.  Speaking to Patients About Diabetes Risk: Is Terminology Important?

Authors:  Valentina D Tarasova; Jaime A Caballero; Paul Turner; Silvio E Inzucchi
Journal:  Clin Diabetes       Date:  2014-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.